Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
$8.3B revenue FY2024 (-8.8% YoY); Q3 FY2025 $2,144M (+5% YoY recovery); Total ARR +16% FY2024, +7% Q3 FY2025; North America best-performing market; industrial automation leader
Rockwell Automation is a global industrial automation and digital transformation company providing control systems, software, sensors, and services for manufacturing and industrial operations. The company offers programmable logic controllers (PLCs), industrial networks, motion control, visualization software, and analytics platforms serving discrete and process manufacturers. Rockwell Automation helps industrial enterprises improve productivity, safety, and sustainability through integrated automation solutions, smart manufacturing technologies, and lifecycle services across diverse industries.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.